Results 111 to 120 of about 2,002 (144)

Systemic Mastocytosis Presenting as Non-cirrhotic Portal Hypertension With Upper Gastrointestinal Bleeding in a Young Female Patient: A Case Report. [PDF]

Cureus
Jangid A, Pandey P, Siddiqui MSI, Tiwari OP, Pandey SK, Singh NK.   +5 more
europepmc   +1 more source

Advances in the Management of Mediator-Related Symptoms in Non-Advanced Systemic Mastocytosis. [PDF]

Immunotargets Ther
Gülen T, Sabato V.
europepmc   +1 more source

Fatal reactions to alpha-gal might be due to comorbid mast cell diseases. [PDF]

J Allergy Clin Immunol Pract
Moraczewski J, Stone CA.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Avapritinib for the Treatment of Indolent Systemic Mastocytosis

Clinical Immunology, 2023
Samer Abdelkader
exaly   +2 more sources

Response of patients with indolent systemic mastocytosis to tamoxifen citrate

Leukemia Research, 2016
We examined whether tamoxifen citrate at 20mg/day for 1 year had a beneficial effect on laboratory findings, bone marrow mastocytosis, common clinical symptoms, or quality-of-life assessment for 5 women and 2 men with indolent systemic mastocytosis. Tamoxifen was well tolerated.
Joseph H, Butterfield, Dong, Chen
openaire   +2 more sources

Indolent systemic mastocytosis: is there a reliable radiographic pattern?

Pediatric Radiology, 2012
A 14-year-old boy undergoing treatment for nephrotic syndrome with steroids and cyclosporine presented with small sclerotic bone lesions in a routine chest radiograph. Similar lesions were found in other bones of the axial and appendicular skeleton. Despite the paucity of clinical symptoms and absence of laboratory data suggesting systemic mastocytosis,
Flávia Silva, Braga, Gabriel Antônio, de Oliviera, Adriana Maria Fonseca, de Melo, Lívia Guidoni, de Assis Barbosa, João Vinícius Cremasco, Fraga   +4 more
openaire   +2 more sources